LIfT BioSciences, a rapidly emerging biotech and world leader in neutrophil immuno-therapies, announces the appointment of Mark A. Exley, PhD as Chief Scientific Officer...
LIfT BioSciences, a rapidly emerging biotech company about to start clinical trials for its first-in-class allogeneic innate cell therapy, announces it has been awarded...
